Skip to main content
Signal8

Tilray Brands, Inc. (TLRY)

Tilray Brands, Inc. is a diversified global consumer packaged goods company primarily involved in the cultivation, processing, marketing, and sale of cannabis products. Its operations span a significant international footprint, encompassing Canada, the United States, Europe, Australia, New Zealand, and Latin America. The company organizes its business across four distinct divisions: Cannabis, Distribution, Beverage Alcohol, and Wellness. Within its cannabis division, Tilray provides a comprehensive range of medical and adult-use items, including regulated products like GMP-certified cannabis flowers, oils, vaporizers, edibles, and topical applications. Beyond cannabis, Tilray's portfolio extends to the procurement and resale of pharmaceutical and wellness goods. Furthermore, it manufactures, promotes, and distributes a variety of alcoholic beverages, alongside hemp-derived food and other wellness items. The company markets its diverse offerings under numerous recognized brands, such as Tilray, Aphria, SweetWater, and Breckenridge Distillery. Its products reach a wide array of customers, including retail outlets, wholesale partners, medical patients, healthcare practitioners, hospitals, pharmacies, scientific researchers, governmental bodies, and directly to end consumers. Formerly operating as Tilray, Inc., the corporation is headquartered in Leamington, Canada.

Sector: Medicinal Chemicals & Botanical Products

Industry: Drug Manufacturers - Specialty & Generic

Tilray Brands, Inc. logo

Tilray Brands, Inc.

NASDAQ:TLRYHealthcare
-4.17%$2.53
AH$2.51-0.78%vs close
Mkt Cap$373.9M
Float147.77M
O/S147.79M
Vol
$ Vol
RVOL
Inst Own9.5%
SI14.6%
Earnings
Dilution
Pipeline1 lead-sponsored trial·0 active1 completed(7 more as collaborator)

Trials need funding. See this company's dilution risk and cash position.

Clinical Trials
Sponsor role
  • Phase 2
    Completed

    Evaluating Safety and Efficacy of Cannabis in Participants With Chronic Posttraumatic Stress Disorder

    High THC/Low CBD Cannabis, High THC/High CBD Cannabis

    Posttraumatic Stress Disorder

    Enrollment
    6
    Start
    Feb 2017
    Primary Completion
    Mar 2019
    Completion
    Mar 2019
    NCT02517424